drugset / Trial / NCT00634959

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

NCT00634959

Phase 2 Completed 37 enrolled ViiV Healthcare Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effects of food and dose regimen on the antiviral effects of Maraviroc (UK-427,857) in patients with human immunodeficiency virus (HIV)

Timeline

Start
2003-07
Primary completion
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Maraviroc Other / unclassified 100 mg Oral
Subject Maraviroc Other / unclassified 150 mg Oral
Subject Maraviroc Other / unclassified 300 mg Oral